Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Attenuated estrogen signaling disrupts placentation and drives trophoblast defects in Down syndrome.

bioRxiv : the preprint server for biology·2026
Same author

Healthcare Burden of Trial-and-Error Contraceptive Prescribing in Adolescents.

Journal of pediatric and adolescent gynecology·2026
Same author

Myostatin inhibition from preconception through lactation improves maternal muscle and skeletal health in the osteogenesis imperfecta murine mouse model.

Bone·2026
Same author

Efficient Fluorescent Labeling of Human Trophoblast Stem Cells via a CRISPR/Cas9-Mediated Knock-In Approach in a Safe Harbor Locus.

Bio-protocol·2026
Same author

Variations in blood levels of the anti-fusogenic endogenous retroviral protein suppressyn are associated with fetal growth outcome in preeclampsia.

Scientific reports·2025
Same author

Two classes of syncytiotrophoblast nuclei form following BAP-driven human pluripotent stem cell differentiation.

Placenta·2025

Related Experiment Video

Updated: May 26, 2026

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
05:31

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas

Published on: January 26, 2024

Preeclampsia: multiple approaches for a multifactorial disease.

Kathleen A Pennington1, Jessica M Schlitt, Daniel L Jackson

  • 1Department of Obstetrics, Gynecology and Women's Health, University of Missouri School of Medicine, 500 North Keene Street, Columbia, MO 65201, USA.

Disease Models & Mechanisms
|January 10, 2012
PubMed
Summary

Preeclampsia, a pregnancy disorder causing hypertension and proteinuria, leads to significant maternal and fetal harm worldwide. Effective treatment remains elusive, highlighting the urgent need for new research approaches.

Related Experiment Videos

Last Updated: May 26, 2026

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
05:31

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas

Published on: January 26, 2024

Area of Science:

  • Obstetrics and Gynecology
  • Maternal-Fetal Medicine
  • Reproductive Biology

Background:

  • Preeclampsia is a serious pregnancy-specific condition marked by hypertension and proteinuria.
  • It is a leading global cause of maternal and fetal morbidity and mortality.
  • Currently, delivery is the only definitive treatment, indicating a gap in understanding and therapeutic options.

Purpose of the Study:

  • To review the current understanding of preeclampsia pathophysiology.
  • To highlight the limitations of existing research models.
  • To emphasize the need for novel approaches in preeclampsia research.

Main Methods:

  • Review of existing literature on preeclampsia.
  • Analysis of common in vitro and animal models used in preeclampsia research.
  • Discussion of pathophysiological mechanisms including placental vascular remodeling and immune interactions.

Main Results:

  • Preeclampsia involves abnormal uterine vascular remodeling by placental trophoblast cells.
  • Common research models focus on placental oxygen dysregulation, trophoblast invasion, vascular damage, and immune interactions.
  • Progress in understanding and treating preeclampsia is slow, despite ongoing investigations.

Conclusions:

  • Preeclampsia is a complex, multifactorial disorder with significant global health implications.
  • Existing research models offer insights but have limitations in fully replicating the human condition.
  • There is a critical need for innovative research strategies, new disease models, and dedicated investigators to advance preeclampsia management.